The present invention relates to new compounds of general formula (I) that show dual activity towards α2δ subunit of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit, and to the noradrenaline transporter (NET). The invention is also related to the process for the preparation of said compounds as well as to compositions comprising them, and to their use as medicaments.
本发明涉及一般式(I)的新化合物,该化合物对电压门控
钙通道(VGCC)的α2δ亚基,特别是α2δ-1亚基,以及
去甲肾上腺素转运蛋白(NET)显示双重活性。该发明还涉及制备所述化合物的方法,以及包含它们的组合物,并将其用作药物。